TRIMEDYNE, INC. (OTCBB: TMED) today announced its chairman, Marvin P. Loeb, Sc.D., was interviewed live by Michael Wax of CEO CAST.
The audio interview will be available for five (5) business days, commencing January 6. To access the interview, please go tohttp://www.ceocast.com, register (which is free) and click on Trimedyne.
Dr. Loeb discussed the Company’s earlier reported increases in revenues and its business and markets, as well as other matters.
Commenting on the interview, Dr. Loeb said, “We are pleased that CEO CAST is advising the investment community of the potential of Trimedyne’s outpatient laser procedures to treat herniated or ruptured discs in the spine, enlarged prostates in men and other conditions.”
About CEO CAST
CEO CAST is a leading online, market news service that brings market insight to investors and features one-on-one live interviews with executives of promising, publicly-held companies.
About Trimedyne
Trimedyne, Inc. is a leading manufacturer of proprietary medical lasers and patented fiber optic devices for performing a variety of minimally invasive procedures as a less traumatic, lower cost alternative to traditional surgery. For additional information, visit Trimedyne’s website at http://www.trimedyne.com.
